Research & Publications
I. Statistical Methodology
- Peer-reviewed journal articles
- psvmSDR: An R package for a unified algorithm for sufficient dimension reduction via principal machines
- A least distance estimator for a multivariate regression model using deep neural networks
- Simultaneous estimation and variable selection for a non-crossing multiple quantile regression using deep neural network
- Concise overview of principal support vector machine
- Peer-reviewed conference proceeding
- Privacy-preserving face redaction using crowdsourcing
- Book
- Introduction to Statistics and Its Application with R
- Submitted or under review
- Penalized principal machines for sufficient dimension reduction and its efficient computation
- SpaDesign: Simulation-based framework for determining sequencing depth for spatial transcriptomics experiments
- Penalized deep support vector machines for nonlinear classification and variable selection
- A unified framework of penalized deep composite quantile regression for simultaneous function estimation and variable selection
- In preparation
- spaCraft: Calibrated power analysis and sample-size planning for multi-sample spatial transcriptomics
- Circular data analysis in spatial omics
- CellPacman: An interpretable machine-learning pipeline for phenotypic discovery and dose-response characterization of Cell Painting assays
II. Biomedical and Collaborative Research
- Peer-reviewed conference abstracts
- Biomarker-driven exploratory clustering of cytokine and hematologic profiles in a Phase II trial of metronomic chemotherapy plus cemiplimab in R/M HNSCCContribution: Lead biostatistician; UMAP-HDBSCAN clustering, cluster characterization, and biomarker-survival analyses.
- Cytokine analysis in a Phase II trial of metronomic carboplatin/paclitaxel plus cemiplimab for recurrent/metastatic head and neck squamous cell carcinomaContribution: Lead biostatistician; longitudinal cytokine analyses, response-group comparisons, multiplicity-adjusted testing, and survival analyses.
- Safety and immunomodulatory effects of siltuximab prophylaxis prior to standard-of-care CD19-directed CAR T-cell therapy for B-cell lymphomas: Final Phase I trial resultsContribution: Lead biostatistician; time-matched cohort comparisons of spectral flow cytometry, cytokine, response, and survival data.
- Decoding immune suppression in Merkel cell carcinoma through integrated spatial transcriptomics and multiplex proteomicsContribution: Lead biostatistician; integrated spatial transcriptomics and multiplex proteomics analysis.
- Clinical manuscripts in preparation
- Phase I study assessing the safety and immunomodulatory effects of prophylactic siltuximab prior to standard-of-care CD19-directed chimeric antigen receptor therapyContribution: Lead statistician; all statistical analyses including mixed models, survival analysis, multivariable regression, and longitudinal analysis.
- Clinical and genomic predictors of hyperprogression in recurrent/metastatic head and neck cancer: Discovery and validationContribution: Lead biostatistician responsible for all statistical analyses.
* Corresponding author. † Equal contribution where indicated. Publication status and wording follow the attached CV.
For citation metrics and the most recent indexing, see my Google Scholar profile.